Vogelstein B, Kinzler KW: Cancer genes and the pathways they control. Nat Med. 2004, 10 (8): 789-799. 10.1038/nm1087. [http://www.ncbi.nlm.nih.gov/pubmed/15286780] [PMID: 15286780]
Article
CAS
PubMed
Google Scholar
Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O’Meara S, Vastrik I, Schmidt EE, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, et al: Patterns of somatic mutation in human cancer genomes. Nature. 2007, 446 (7132): 153-158. 10.1038/nature05610. [http://www.nature.com/doifinder/10.1038/nature05610]
Article
PubMed Central
CAS
PubMed
Google Scholar
Weinstein IB, Joe AK: Mechanisms of disease: Oncogene addiction-a rationale for molecular targeting in cancer therapy. Nat Clin Pract Oncol. 2006, 3 (8): 448-457. 10.1038/ncponc0558. [http://www.ncbi.nlm.nih.gov/pubmed/16894390] [PMID: 16894390]
Article
CAS
PubMed
Google Scholar
Torkamani A, Schork NJ: Prediction of cancer driver mutations in protein kinases. Cancer Res. 2008, 68 (6): 1675-1682. 10.1158/0008-5472.CAN-07-5283. [http://www.ncbi.nlm.nih.gov/pubmed/18339846] [PMID: 18339846]
Article
CAS
PubMed
Google Scholar
Bardelli A, Parsons DW, Silliman N, Ptak J, Szabo S, Saha S, Markowitz S, Willson JKV, Parmigiani G, Kinzler KW, Vogelstein B, Velculescu VE: Mutational analysis of the tyrosine kinome in colorectal cancers. Sci (New York, N.Y.). 2003, 300 (5621): 949-10.1126/science.1082596. [http://www.ncbi.nlm.nih.gov/pubmed/12738854] [PMID: 12738854]
Article
CAS
Google Scholar
Ye J, Pavlicek A, Lunney EA, Rejto PA, Teng C: Statistical method on nonrandom clustering with application to somatic mutations in cancer. BMC Bioinformatics. 2010, 11: 11-10.1186/1471-2105-11-11. [http://www.biomedcentral.com/1471-2105/11/11]
Article
PubMed Central
PubMed
Google Scholar
Wagner A: Rapid detection of positive selection in genes and genomes through variation clusters. Genetics. 2007, 176 (4): 2451-2463. 10.1534/genetics.107.074732.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sjöblom T, Jones S, Wood LD, Parsons DW, Lin J, Barber TD, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JKV, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE: The consensus coding sequences of human breast and colorectal cancers. Sci (New York, N.Y.). 2006, 314 (5797): 268-274. 10.1126/science.1133427. [http://www.ncbi.nlm.nih.gov/pubmed/16959974] [PMID: 16959974]
Article
Google Scholar
Kreitman M: Methods to detect selection in populations with applications to the human. Ann Rev Genomics Hum Genet. 2000, 1: 539-559. 10.1146/annurev.genom.1.1.539.
Article
CAS
Google Scholar
Wang T: Prevalence of somatic alterations in the colorectal cancer cell genome. Proc Natl Acad Sci. 2002, 99 (5): 3076-3080. 10.1073/pnas.261714699.
Article
PubMed Central
CAS
PubMed
Google Scholar
Reva B, Antipin Y, Sander C: Predicting the functional impact of protein mutations: application to cancer genomics. Nucleic Acids Res. 2011, 39 (17): e118-e118. 10.1093/nar/gkr407.
Article
PubMed Central
CAS
PubMed
Google Scholar
Breiman L: Random forests. Mach Learn. 2001, 45: 5-32. 10.1023/A\%3A1010933404324.
Article
Google Scholar
Cortes C, Vapnik V: Support-vector networks. Mach Learn. 1995, 20 (3): 273-297. [http://www.springerlink.com/index/10.1007/BF00994018]
Google Scholar
Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, Kondrashov AS, Sunyaev SR: A method and server for predicting damaging missense mutations. Nat Methods. 2010, 7 (4): 248-249. 10.1038/nmeth0410-248. [http://www.nature.com/doifinder/10.1038/nmeth0410-248]
Article
PubMed Central
CAS
PubMed
Google Scholar
Carter H, Chen S, Isik L, Tyekucheva S, Velculescu VE, Kinzler KW, Vogelstein B, Karchin R: Cancer-specific high-throughput annotation of somatic mutations: computational prediction of driver missense mutations. Cancer Res. 2009, 69 (16): 6660-6667. 10.1158/0008-5472.CAN-09-1133.
Article
PubMed Central
CAS
PubMed
Google Scholar
Forbes SA, Bhamra G, Bamford S, Dawson E, Kok C, Clements J, Menzies A, Teague JW, Futreal PA, Stratton MR: The Catalogue of Somatic Mutations in Cancer (COSMIC). Curr Protoc Hum Genet. 2008, Chapter 10: Unit 10.11-[http://www.ncbi.nlm.nih.gov/pubmed/18428421] [PMID: 18428421]
CAS
PubMed
Google Scholar
Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat T, Weissig H, Shindyalov I, Bourne P: The protein data bank. Nucleic Acids Res. 2000, 28: 235-242. 10.1093/nar/28.1.235. [http://www.pdb.org]
Article
PubMed Central
CAS
PubMed
Google Scholar
Borg I, Groenen PJF: Modern multidimensional scaling : theory and applications. 1997, New York: Springer
Book
Google Scholar
The UniProt Consortium: Reorganizing the protein space at the Universal Protein Resource (UniProt). Nucleic Acids Res. 2011, 40 (D1): D71-D75. 10.1093/nar/gkr981.
Article
PubMed Central
Google Scholar
Pages H, Aboyoun P, Gentleman R, DebRoy S: Biostrings: String objects representing biological sequences, and matching algorithms. R package version 2.28.0.
Tong Y, Tempel W, Shen L, Arrowsmith C, Edwards A, Sundstrom M, Weigelt J, Park H, Bockharev A: Human K-Ras in complex with a GTP analogue. 2009, [http://www.rcsb.org/pdb/explore.do?structureId=3GFT]
Google Scholar
Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B (Methodological). 1995, 57: 289-300. [http://www.jstor.org/stable/2346101]
Google Scholar
Dunn OJ: Confidence intervals for the means of dependent, normally distributed variables. J Am Stat Assoc. 1959, 54 (287): 613-621. 10.1080/01621459.1959.10501524. [http://www.jstor.org/stable/2282541]
Article
Google Scholar
Dunn OJ: Multiple comparisons among means. J Am Stat Assoc. 1961, 56 (293): 52-64. 10.1080/01621459.1961.10482090. [http://www.jstor.org/stable/2282330]
Article
Google Scholar
Gong Y, Kakihara Y, Krogan N, Greenblatt J, Emili A, Zhang Z, Houry WA: An atlas of chaperone-protein interactions in Saccharomyces cerevisiae: implications to protein folding pathways in the cell. Mol Syst Biol. 2009, 5: [http://www.nature.com/doifinder/10.1038/msb.2009.26]
Google Scholar
Mankoo PK, Sukumar S, Karchin R: PIK3CA somatic mutations in breast cancer: Mechanistic insights from Langevin dynamics simulations. Proteins: Struct, Funct, Bioinformatics. 2009, 75 (2): 499-508. 10.1002/prot.22265.
Article
CAS
Google Scholar
Herbst RS: Review of epidermal growth factor receptor biology. Int J Radiat Oncol *Biology* Phys. 2004, 59 (2, Supplement): S21-S26. 10.1016/j.ijrobp.2003.11.041. [http://www.sciencedirect.com/science/article/pii/S0360301604003311]
Article
Google Scholar
Scagliotti GV, Selvaggi G, Novello S, Hirsch FR: The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res. 2004, 10 (12): 4227s-4232s. 10.1158/1078-0432.CCR-040007. [http://clincancerres.aacrjournals.org/content/10/12/4227s.abstract]
Article
CAS
PubMed
Google Scholar
Walker F, Abramowitz L, Benabderrahmane D, Duval X, Descatoire V, Hénin D, Lehy T, Aparicio T: Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus. Hum Pathol. 2009, 40 (11): 1517-1527. 10.1016/j.humpath.2009.05.010. [http://www.sciencedirect.com/science/article/pii/S004681770900197X]
Article
CAS
PubMed
Google Scholar
Heimberger AB, Hlatky R, Suki D, Yang D, Weinberg J, Gilbert M, Sawaya R, Aldape K: Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients. Clin Cancer Res. 2005, 11 (4): 1462-1466. 10.1158/1078-0432.CCR-04-1737. [http://clincancerres.aacrjournals.org/content/11/4/1462.abstract]
Article
CAS
PubMed
Google Scholar
Zhang X, Gureasko J, Shen K, Cole PA, Kuriyan J: An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor. Cell. 2006, 125 (6): 1137-1149. 10.1016/j.cell.2006.05.013. [http://www.sciencedirect.com/science/article/pii/S0092867406005848]
Article
CAS
PubMed
Google Scholar
Yun CH, Boggon TJ, Li Y, Woo MS, Greulich H, Meyerson M, Eck MJ: Structures of lung cancer-derived EGFR mutants and inhibitor complexes: mechanism of activation and insights into differential inhibitor sensitivity. Cancer Cell. 2007, 11 (3): 217-227. 10.1016/j.ccr.2006.12.017. [http://www.ncbi.nlm.nih.gov/pubmed/17349580] [PMID: 17349580]
Article
PubMed Central
CAS
PubMed
Google Scholar
Tam IYS, Chung LP, Suen WS, Wang E, Wong MCM, Ho KK, Lam WK, Chiu SW, Girard L, Minna JD, Gazdar AF, Wong MP: Distinct epidermal growth factor receptor and KRAS mutation patterns in non-small cell lung cancer patients with different tobacco exposure and clinicopathologic features. Clin Cancer Res. 2006, 12 (5): 1647-1653. 10.1158/1078-0432.CCR-05-1981. [http://www.ncbi.nlm.nih.gov/pubmed/16533793] [PMID: 16533793]
Article
CAS
PubMed
Google Scholar
Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, Herman P, Kaye FJ, Lindeman N, Boggon TJ, Naoki K, Sasaki H, Fujii Y, Eck MJ, Sellers WR, Johnson BE, Meyerson M: EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Sci (New York, N.Y.). 2004, 304 (5676): 1497-1500. 10.1126/science.1099314. [http://www.ncbi.nlm.nih.gov/pubmed/15118125] [PMID: 15118125]
Article
CAS
Google Scholar
Peraldo-Neia C, Migliardi G, Mello-Grand M, Montemurro F, Segir R, Pignochino Y, Cavalloni G, Torchio B, Mosso L, Chiorino G, Aglietta M: Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer. BMC Cancer. 2011, 11: 31-10.1186/1471-2407-11-31. [http://www.biomedcentral.com/1471-2407/11/31]
Article
PubMed Central
CAS
PubMed
Google Scholar
Tsao MS, Sakurada A, Cutz JC, Zhu CQ, Kamel-Reid S, Squire J, Lorimer I, Zhang T, Liu N, Daneshmand M, Marrano P, da Cunha Santos G, Lagarde A, Richardson F, Seymour L, Whitehead M, Ding K, Pater J, Shepherd FA: Erlotinib in lung cancer - molecular and clinical predictors of outcome. N Engl J Med. 2005, 353 (2): 133-144. 10.1056/NEJMoa050736.
Article
CAS
PubMed
Google Scholar
Yun CH, Mengwasser KE, Toms AV, Woo MS, Greulich H, Wong KK, Meyerson M, Eck MJ: The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP. Proc Natl Acad Sci U S A. 2008, 105 (6): 2070-2075. 10.1073/pnas.0709662105. [http://www.ncbi.nlm.nih.gov/pubmed/18227510] [PMID: 18227510]
Article
PubMed Central
CAS
PubMed
Google Scholar
Masago K, Fujita S, Irisa K, Kim YH, Ichikawa M, Mio T, Mishima M: Good clinical response to Gefitinib in a non-small cell lung cancer patient harboring a rare somatic epidermal growth factor gene point mutation; codon 768 AGC > ATC in Exon 20 (S768I). Jpn J Clin Oncol. 2010, 40 (11): 1105-1109. 10.1093/jjco/hyq087. [http://jjco.oxfordjournals.org/content/40/11/1105.abstract]
Article
PubMed
Google Scholar
Kranenburg O: The KRAS oncogene: Past, present, and future. Biochim Biophys Acta (BBA) - Rev Cancer. 2005, 1756 (2): 81-82. 10.1016/j.bbcan.2005.10.001. [http://www.sciencedirect.com/science/article/pii/S0304419X05000624] [The KRAS Oncogene]
Article
CAS
Google Scholar
Lee KH, Lee JS, Suh C, Kim SW, Kim SB, Lee JH, Lee MS, Park MY, Sun HS, Kim SH: Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases. Cancer. 1995, 75 (12): 2794-2801. 10.1002/1097-0142(19950615)75:12<2794::AID-CNCR2820751203>3.0.CO;2-F. [http://www.ncbi.nlm.nih.gov/pubmed/7773929] [PMID: 7773929]
Article
CAS
PubMed
Google Scholar
Motojima K, Urano T, Nagata Y, Shiku H, Tsurifune T, Kanematsu T: Detection of point mutations in the Kirsten-ras oncogene provides evidence for the multicentricity of pancreatic carcinoma. Ann Surg. 1993, 217 (2): 138-143. 10.1097/00000658-199302000-00007. [http://www.ncbi.nlm.nih.gov/pubmed/8439212] [PMID: 8439212]
Article
PubMed Central
CAS
PubMed
Google Scholar
Nakano H, Yamamoto F, Neville C, Evans D, Mizuno T, Perucho M: Isolation of transforming sequences of two human lung carcinomas: structural and functional analysis of the activated c-K-ras oncogenes. Proc Natl Acad Sci U S A. 1984, 81: 71-75. 10.1073/pnas.81.1.71. [http://www.ncbi.nlm.nih.gov/pubmed/6320174] [PMID: 6320174]
Article
PubMed Central
CAS
PubMed
Google Scholar
Santos E, Martin-Zanca D, Reddy EP, Pierotti MA, Della Porta G, Barbacid M: Malignant activation of a K-ras oncogene in lung carcinoma but not in normal tissue of the same patient. Sci (New York, N.Y.). 1984, 223 (4637): 661-664. 10.1126/science.6695174. [http://www.ncbi.nlm.nih.gov/pubmed/6695174] [PMID: 6695174]
Article
CAS
Google Scholar
Wenglowsky S, Ren L, Ahrendt KA, Laird ER, Aliagas I, Alicke B, Buckmelter AJ, Choo EF, Dinkel V, Feng B, Gloor SL, Gould SE, Gross S, Gunzner-Toste J, Hansen JD, Hatzivassiliou G, Liu B, Malesky K, Mathieu S, Newhouse B, Raddatz NJ, Ran Y, Rana S, Randolph N, Risom T, Rudolph J, Savage S, Selby LT, Shrag M, Song K, et al: Pyrazolopyridine inhibitors of B-Raf V600E. Part 1: the development of selective, orally Bioavailable, and efficacious inhibitors. ACS Med Chem Lett. 2011, 2 (5): 342-347. 10.1021/ml200025q.
Article
PubMed Central
CAS
PubMed
Google Scholar
Gandhi J, Zhang J, Xie Y, Soh J, Shigematsu H, Zhang W, Yamamoto H, Peyton M, Girard L, Lockwood WW, Lam WL, Varella-Garcia M, Minna JD, Gazdar AF: Alterations in genes of the EGFR signaling pathway and their relationship to EGFR tyrosine kinase inhibitor sensitivity in lung cancer cell lines. PLoS ONE. 2009, 4 (2): e4576-10.1371\%2Fjournal.pone.0004576.
Article
PubMed Central
PubMed
Google Scholar
Pratilas CA, Hanrahan AJ, Halilovic E, Persaud Y, Soh J, Chitale D, Shigematsu H, Yamamoto H, Sawai A, Janakiraman M, Taylor BS, Pao W, Toyooka S, Ladanyi M, Gazdar A, Rosen N, Solit DB: Genetic predictors of MEK dependence in non-small cell lung cancer. Cancer Res. 2008, 68 (22): 9375-9383. 10.1158/0008-5472.CAN-08-2223.
Article
PubMed Central
CAS
PubMed
Google Scholar
Lee JW, Yoo NJ, Soung YH, Kim HS, Park WS, Kim SY, Lee JH, Park JY, Cho YG, Kim CJ, Ko YH, Kim SH, Nam SW, Lee JY, Lee SH: BRAFmutations in non-Hodgkin’s lymphoma. Br J Cancer. 2003, 89 (10): 1958-1960. 10.1038/sj.bjc.6601371. [http://www.ncbi.nlm.nih.gov/pubmed/14612909] [PMID: 14612909]
Article
PubMed Central
CAS
PubMed
Google Scholar
Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S, Teague J, Woffendin H, Garnett MJ, Bottomley W, Davis N, Dicks E, Ewing R, Floyd Y, Gray K, Hall S, Hawes R, Hughes J, Kosmidou V, Menzies A, Mould C, Parker A, Stevens C, Watt S, Hooper S, Wilson R, Jayatilake H, Gusterson BA, Cooper C, Shipley J, et al: Mutations of the BRAF gene in human cancer. Nature. 2002, 417 (6892): 949-954. 10.1038/nature00766. [http://www.ncbi.nlm.nih.gov/pubmed/12068308] [PMID: 12068308]
Article
CAS
PubMed
Google Scholar
Naoki K, Chen TH, Richards WG, Sugarbaker DJ, Meyerson M: Missense mutations of the BRAF gene in human lung adenocarcinoma. Cancer Res. 2002, 62 (23): 7001-7003. [http://www.ncbi.nlm.nih.gov/pubmed/12460919] [PMID: 12460919]
CAS
PubMed
Google Scholar
Andreu-Pérez P, Esteve-Puig R, de Torre-Minguela C, López-Fauqued M, Bech-Serra JJ, Tenbaum S, García-Trevijano ER, Canals F, Merlino G, Avila MA, Recio JA: Protein arginine methyltransferase 5 regulates ERK1/2 signal transduction amplitude and cell fate through CRAF. Sci signaling. 2011, 4 (190): ra58-10.1126/scisignal.2001936. [http://www.ncbi.nlm.nih.gov/pubmed/21917714] [PMID: 21917714]
Article
Google Scholar
Hingorani SR, Jacobetz MA, Robertson GP, Herlyn M, Tuveson DA: Suppression of BRAF(V599E) in human melanoma abrogates transformation. Cancer Res. 2003, 63 (17): 5198-5202. [http://www.ncbi.nlm.nih.gov/pubmed/14500344] [PMID: 14500344]
CAS
PubMed
Google Scholar
Rajagopalan H, Bardelli A, Lengauer C, Kinzler KW, Vogelstein B, Velculescu VE: Tumorigenesis: RAF/RAS oncogenes and mismatch-repair status. Nature. 2002, 418 (6901): 934-10.1038/418934a. [http://www.ncbi.nlm.nih.gov/pubmed/12198537] [PMID: 12198537]
Article
CAS
PubMed
Google Scholar
Chapman MA, Lawrence MS, Keats JJ, Cibulskis K, Sougnez C, Schinzel AC, Harview CL, Brunet JP, Ahmann GJ, Adli M, Anderson KC, Ardlie KG, Auclair D, Baker A, Bergsagel PL, Bernstein BE, Drier Y, Fonseca R, Gabriel SB, Hofmeister CC, Jagannath S, Jakubowiak AJ, Krishnan A, Levy J, Liefeld T, Lonial S, Mahan S, Mfuko B, Monti S, Perkins LM, et al: Initial genome sequencing and analysis of multiple myeloma. Nature. 2011, 471 (7339): 467-472. 10.1038/nature09837.
Article
PubMed Central
CAS
PubMed
Google Scholar
Sved J, Bird A: The expected equilibrium of the CpG dinucleotide in vertebrate genomes under a mutation model. Proc Natl Acad Sci. 1990, 87 (12): 4692-4696. 10.1073/pnas.87.12.4692. [http://www.pnas.org/content/87/12/4692.abstract]
Article
PubMed Central
CAS
PubMed
Google Scholar
Hollstein M, Sidransky D, Vogelstein B, Harris CC: p53 mutations in human cancers. Sci (New York, N.Y.). 1991, 253 (5015): 49-53. 10.1126/science.1905840. [http://www.ncbi.nlm.nih.gov/pubmed/1905840] [PMID: 1905840]
Article
CAS
Google Scholar